How Much Did Rythm Raise?
Funding & Key Investors

Rythm has successfully secured a significant capital injection, bringing its total funding to $11M. This latest financing round, which accounts for $11M, underscores the company's pivotal role in the burgeoning neurotechnology sector. By leveraging this major strategic investment, the firm is well-positioned to accelerate its research and development initiatives, further solidifying its commitment to enhancing human health through advanced brain-monitoring technology.

What is Rythm?

Rythm
ManufacturingTest & Measurement EquipmentBusiness Services

Rythm operates at the intersection of neuroscience, machine learning, and consumer electronics. The company is best known for its flagship product, Dreem, an active wearable device engineered to optimize sleep quality through sophisticated neuro-feedback loops. By integrating expertise from sleep medicine, engineering, and advanced computing, Rythm has established a unique market position that bridges the gap between clinical-grade research and accessible consumer health solutions. With a dual presence in Paris and San Francisco, the organization maintains a robust collaborative network with leading hospitals and research institutions to validate its proprietary technology. The company's multidisciplinary team of over 70 professionals is dedicated to decoding complex neurological data to improve overall quality of life.

How much funding has Rythm raised?

Rythm has raised a total of $11M across 1 funding round:

2016

Unspecified

$11M

Unspecified (2016): $11M, investors not publicly disclosed

Key Investors in Rythm

Undisclosed Investor

Undisclosed investor participating in the funding round.

Undisclosed Investor

Undisclosed investor participating in the funding round.

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for Rythm?

With this major enterprise-level funding, Rythm is poised to transition from its initial product launch phase into a broader commercial scaling strategy. The capital will likely be deployed to refine the Dreem ecosystem, expand its clinical validation studies, and potentially diversify its product portfolio into other areas of cognitive health. As the company continues to collaborate with global research entities, the focus will remain on scaling its operational infrastructure to meet the growing demand for data-driven sleep solutions. Investors are closely monitoring how Rythm will leverage its proprietary neuroscience platform to capture a larger share of the global health-tech market, particularly as the industry shifts toward personalized, evidence-based wellness interventions.

See full Rythm company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Food & BeverageManufacturing
ManufacturingPlastic, Packaging & Containers
ManufacturingPharmaceuticalsBusiness ServicesResearch & Development
ManufacturingPulp & PaperPlastic, Packaging & Containers

Frequently Asked Questions Regarding Rythm Financial Insights

What are the most recent funding rounds that Rythm has completed, and what were the funding rounds?
Rythm has recently completed 1 funding rounds: Unspecified on Mar 28, 2016.
What is the total amount of funding Rythm has raised to date?
Rythm has raised a total of $11M in funding to date.
How many funding rounds has Rythm completed?
Rythm has completed 1 funding rounds.
How much funding did Rythm raise in its most recent funding round?
Rythm raised $11M in its most recent funding round.
Which was the largest funding round in Rythm's history?
The largest funding round in Rythm's history was $11M.
See more information about Rythm